About
Contact
Subscribe
e-Edition

Make Home Page

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

- Site search

Home
News
Sports
- Local Sports
- National Sports
Business
Opinion
A & E
Life
Features & Magazines
Classifieds
Weather
Obituaries
Parcel Pickup

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Organon & Co. Common Stock (NY:OGN)

8.005 +0.485 (+6.45%)

Streaming Delayed Price Updated: 2:05 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Organon & Co. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2025

February 12, 2026

From Organon & Co.

Via Business Wire

Organon To Report Fourth Quarter and Full Year 2025 Results and Host Conference Call on February 12, 2026

January 29, 2026

From Organon & Co.

Via Business Wire

Organon Completes Divestiture of JADA® System to Laborie

January 28, 2026

From Organon & Co.

Via Business Wire

Organon Announces US Food and Drug Administration Approval of Supplemental New Drug Application Extending Duration of Use of NEXPLANON® (etonogestrel implant) 68 mg Radiopaque

January 16, 2026

From Organon & Co.

Via Business Wire

Organon To Present at the Piper Sandler 37th Annual Healthcare Conference

November 25, 2025

From Organon & Co.

Via Business Wire

Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US

November 17, 2025

From Organon & Co.

Via Business Wire

Organon Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Organon & Co. - OGN

November 14, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

Organon Reports Results for the Third Quarter Ended September 30, 2025

November 10, 2025

From Organon & Co.

Via Business Wire

New Data Show Early and Consistent Response to VTAMA® (tapinarof) Cream, 1%, in Children Aged 2+ with Atopic Dermatitis, Including Those With Associated Comorbidities

November 08, 2025

From Organon & Co.

Via Business Wire

Organon Announces Agreement to Divest its JADA® System for Up to $465 Million to Laborie

November 07, 2025

From Organon & Co.

Via Business Wire

Organon To Report Third Quarter 2025 Results and Host Conference Call on November 10, 2025

November 06, 2025

From Organon & Co.

Via Business Wire

Organon Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Organon & Co. - OGN

October 28, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

Kaplan Fox is Investigating Organon & Co. (OGN) Following an Announcement of Findings of an Audit Committee Investigation and CEO Resignation

October 27, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Kaplan Fox is Investigating Organon & Co. (OGN) Following an Announcement of Findings of an Audit Committee Investigation and CEO Resignation

October 27, 2025

Via TheNewswire.com

Organon Appoints Company Executive Joseph Morrissey as Interim CEO and Board Chair Carrie Cox as Executive Chair; Announces Results of Audit Committee Investigation

October 27, 2025

From Organon

Via Business Wire

US Food and Drug Administration (FDA) Approves Henlius and Organon’s BILDYOS® (denosumab-nxxp) and BILPREVDA® (denosumab-nxxp), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively

September 02, 2025

From Organon & Co.

Via Business Wire

Organon Reports Results for the Second Quarter Ended June 30, 2025

August 05, 2025

From Organon & Co.

Via Business Wire

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon

July 22, 2025

From Faruqi & Faruqi, LLP

Via Business Wire

Organon & Co. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before July 22, 2025 to Discuss Your Rights - OGN

July 22, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

Organon & Co. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before July 22, 2025 to Discuss Your Rights - OGN

July 22, 2025

Via TheNewswire.com

Topics Fraud Lawsuit

ORGANON FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Organon & Co. (OGN) Investors of the July 22nd Deadline and Urges Them to Inquire About Their Rights in Class Action Lawsuit

July 22, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Organon To Report Second Quarter 2025 Results and Host Conference Call on August 5, 2025

July 22, 2025

From Organon & Co.

Via Business Wire

Deadline Soon: Organon & Co. (OGN) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

July 21, 2025

From The Law Offices of Frank R. Cruz

Via Business Wire

DEADLINE TOMORROW: Berger Montague Advises Organon & Co. (NYSE: OGN) Investors to Inquire About a Securities Fraud Class Action by July 22, 2025

July 21, 2025

From Berger Montague

Via GlobeNewswire

Organon & Co. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - OGN

July 21, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

Organon & Co. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - OGN

July 21, 2025

Via TheNewswire.com

Topics Fraud Lawsuit

ORGANON & CO. (NYSE: OGN) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Organon & Co. Investors of Upcoming Deadline

July 21, 2025

From Bernstein Liebhard LLP

Via GlobeNewswire

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon

July 20, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

ORGANON DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Organon & Co. (OGN) Investors of the July 22nd Deadline and Urges Them to Inquire About Their Rights in Class Action Lawsuit

July 19, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

ORGANON 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Organon & Co. - OGN

July 18, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Opinion
Photo Galleries
Videos
Local Events
Classifieds
Obituaries

Services

About
Contact
Personnel
Advertise
Subscription Services
Promote Your Event
Dealer Locations
Email Alerts
Submission Forms

Contact Information

chroniclejournal.com
75 S. Cumberland Street
Thunder Bay, ON P7B 1A3
Phone: 807 343 6200
Email: circulation@chroniclejournal.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Organon & Co. Common Stock (NY:OGN)

Press Releases about Organon & Co. Common Stock

Sections

Services

Contact Information

Follow Us